细胞健康筛查市场 - 全球行业规模、份额、趋势、机遇和预测，2018-2028 年：按测试类型、样本、采集点和地区细分

在预测期内，全球细胞健康筛查市场预计将出现惊人的增长。

这很可能是由于久坐不动的生活方式的兴起和人口老龄化，导致糖尿病和肥胖等疾病的出现。 此外，为保持健康生活而采用端粒性能计划（例如健康饮食和锻炼）的人数正在增加，健康预期寿命的重要性日益增加，并且采用直接面向客户的方法也越来越多。因此，预计在预测期内会有显着增长。 此外，全球范围内易患各种疾病和肥胖的老年人口不断增加，进一步增加了对细胞健康筛查的需求，预计这将推动市场增长至 2028 年。 此外，由于饮食不当以及各种慢性疾病，全球越来越多的癌症患者也在预测期内增加了对细胞健康检查的需求。 据估计，今年美国将有 66,470 人（48,520 名男性和 17,950 名女性）被诊断出患有头颈癌。 同样，越来越多的用于製造新药和补充剂的各种临床前研究的研发项目也在预测期内增加了对细胞健康筛查市场的需求。

慢性病患病率的增加推动了市场增长。

在预测期内，越来越多地采用端粒性能计划预计将为全球细胞健康筛查市场带来利润丰厚的增长。 慢性病患病率的增加增加了对健康生活方式的需求，预计这将推动市场增长多年。 2001 年全球约 46% 的疾病和 5650 万人死亡中的 60% 是由慢性病引起的。 多种因素参与细胞衰老的变化，包括体力活动、睡眠和心理障碍。 过度的吸烟和饮酒习惯也会导致各种慢性疾病，使细胞健康检查变得更加苛刻。 端粒检测的使用为临床医生提供了对代谢和遗传疾病的洞察力，为患者提供早期诊断和及时的个性化治疗计划。 然而，对细胞筛选的认识和研究不断增加导致对试剂盒检测的需求不断增加，预计这将在预测期内进一步推动市场增长。 根据美国国家癌症研究所的数据，2018 年美国诊断出 1,735,350 例新的癌症病例。

不断增长的老年人口推动市场增长

由于人口增长、过度饮酒、吸烟、缺乏锻炼、高体重指数以及水果和蔬菜摄入量低，预计糖尿病和肥胖症等生活方式相关疾病的患病率会增加. 预计在此期间市场将进一步增长。 预计老年人口的增加以及随之而来的对细胞健康筛查的需求将推动市场增长。 2020 年，估计美国将诊断出 1,806,590 名新癌症患者，606,520 人将死于该病。

近期发展

• 例如，LabCorp 于 2022 年 4 月宣布，它已针对其提供的各种诊断和筛查测试推出了上门收集服务。
• 例如，2020 年 9 月，Genova Diagnostics 与 LifeLabs 的子公司 Rocky Mountain Analytical 合作。 该合作伙伴关係将使加拿大患者和诊所更容易获得 Genova 的测试。

可自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

• 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

• 市场定义
• 市场范围
  • 目标市场
  • 研究目标年份
  • 主要市场细分

第二章研究方法论

• 调查目的
• 基线调查方法
• 主要行业合作伙伴
• 主要协会和次要信息
• 调查方法
• 数据三角测量和验证
• 假设和限制

第 3 章执行摘要

• 市场概览
• 主要市场细分概述
• 主要市场参与者概览
• 主要地区/国家概览
• 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第 5 章全球细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型（单测试面板/多测试面板）
  • 通过样本（血液、唾液、尿液等）
  • 按收集点（家庭、医院/诊所、诊断机构等）
  • 按地区
  • 按公司分类（2022 年）
• 市场地图
  • 按测试类型
  • 按样本
  • 按收集站点
  • 按地区

第六章北美细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型
  • 按样本
  • 按收集点
  • 按国家
• 北美：国家/地区分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章欧洲细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型
  • 按样本
  • 按收集站点
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第八章亚太地区细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型
  • 按样本
  • 按收集点
  • 按国家
• 亚太地区：国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章南美细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型
  • 按样本
  • 按收集点
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章中东和非洲细胞健康筛查市场展望

• 市场规模和预测
  • 按数量
• 市场份额和预测
  • 按测试类型
  • 按样本
  • 按收集点
  • 按国家
• MEA：国家分析
  • 南非细胞健康检查
  • 沙特阿拉伯细胞健康检查
  • 阿联酋细胞健康检查

第 11 章市场动态

• 司机
• 任务

第12章市场趋势与发展

• 近期趋势
• 併购
• 产品发布

第13章竞争格局

• 业务概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT 分析
  • Telomere Diagnostics, Inc.
  • Quest Diagnostics, Inc.
  • Laboratory Corporation of America Holdings
  • SpectraCell Laboratories, Inc.
  • Cell Science Systems Corporation
  • Immundiagnostik AG
  • Repeat Diagnostics, Inc.
  • OPKO Health, Inc.
  • Genova Diagnostics, Inc.
  • Titanovo, Inc.

第 14 章战略建议

The Global Cellular Health Screening Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing sedentary lifestyle and an aging population, consequently resulting in diseases like diabetes and obesity. Additionally, the growing adoption of telomere performance programs for maintaining a healthy life, such as maintaining a healthy weight with healthy eating, exercise regularly along with the growing importance of healthy life expectancy and the growing adoption of direct to customer approach, is expected to create significant growth during the forecasted period. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cellular health screening, thereby fuelling market growth through 2028. Besides, the growing number of cancer patients due to bad food habits across the globe, along with different chronic diseases, is increasing the demand for cellular health screening during the forecast period. This year, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States. Similarly, an increase in research and development projects for different pre-clinical studies can make new drugs or supplements enhance the demand for the cellular health screening market in the forecast period.

The growing Prevalence of Chronic Diseases is Driving the Market's Growth.

Increasing adoption of telomere performance programs is expected to create lucrative growth for the global cellular health screening market during the forecast period. Due to the increasing prevalence of chronic diseases, the demand for leading a healthy lifestyle has increased, which is further expected to drive market growth over the years. Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions. Different factors are responsible for changes in cellular aging, such as physical activity, sleep, and psychological disorders. Also, excessive smoking and drinking habits can create different types of chronic diseases, which will further demand cellular health screening. The usage of telomere tests provides clinicians with insights into metabolic and genetic diseases with early diagnosis and timely personalized treatment plans for patients. However, growing awareness and research about cellular screening have led to a rise in the demand for kit tests, which is further expected to boost the market growth during the forecast period. According to the National Cancer Institute, in 2018, there were 1,735,350 new cancer cases diagnosed in the United States.

Increasing Geriatric Population Propelling the Market Growth

The increasing prevalence rate of lifestyle disorders such as diabetes and obesity, excessive alcohol consumption, tobacco use, low physical activity, high body mass index, and low intake of fruits and vegetables because of a growing population is further expected to create a lucrative growth of the market during the forecast period. The growing geriatric population and its consequent growth are expected to raise the demand for cellular health screening, in turn propelling the growth of the market. In 2020, an estimated 1,806,590 new cases of cancer were diagnosed in the United States, and 606,520 people died from the disease.

Market Segmentation

The global cellular health screening market can be segmented by test type, sample, site of collection, and by region. Based on test type, the market can be divided into Single Test Panels v/s Multi Test Panels. Based on the sample, the market can be segmented into Blood, Saliva, Urine, and Others. Based on the site of collection, the market can be differentiated into homes, Hospitals & Clinics, Diagnostic Laboratories, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global cellular health screening market on account of the growing demand for maintaining healthy life expectancy, along with the growing adoption of new technology in the country.

Market Players

Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. are some of the leading players operating in the Global Cellular Health Screening Market.

Recent Developments

• For instance, Lab Corp announced in April 2022 that it has launched a home collection service for various diagnostic and screening test offerings of the company.

• For example, in September 2020, Genova Diagnostics partnered with Rocky Mountain Analytical, a subsidiary of LifeLabs. The partnership allowed greater accessibility of Genova's tests for Canadian patients and clinics.

Report Scope

In this report, global cellular health screening systems market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cellular Health Screening Market, By Test Type:

• Single Test Panels
• Multi-Test Panels

Cellular Health Screening Market, By Sample:

• Blood
• Saliva
• Urine
• Others

Cellular Health Screening Market, By Site of Collection:

• Home
• Hospitals & Clinics
• Diagnostic Laboratories
• Others

Cellular Health Screening Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cellular Health Screening Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cellular Health Screening Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (Single Test Panels v/s Multi Test Panels)
  • 5.2.2. By Sample (Blood, Saliva, Urine, Others)
  • 5.2.3. By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map
  • 5.3.1. By Test Type
  • 5.3.2. By Sample
  • 5.3.3. By Site of Collection
  • 5.3.4. By Region

6. North America Cellular Health Screening Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Sample
  • 6.2.3. By Site of Collection
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cellular Health Screening Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Sample
      • 6.3.1.2.3. By Site of Collection
  • 6.3.2. Canada Cellular Health Screening Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Sample
      • 6.3.2.2.3. By Site of Collection
  • 6.3.3. Mexico Cellular Health Screening Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Sample
      • 6.3.3.2.3. By Site of Collection

7. Europe Cellular Health Screening Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Sample
  • 7.2.3. By Site of Collection
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Cellular Health Screening Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Sample
      • 7.3.1.2.3. By Site of Collection
  • 7.3.2. Germany Cellular Health Screening Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Sample
      • 7.3.2.2.3. By Site of Collection
  • 7.3.3. United Kingdom Cellular Health Screening Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Sample
      • 7.3.3.2.3. By Site of Collection
  • 7.3.4. Italy Cellular Health Screening Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Sample
      • 7.3.4.2.3. By Site of Collection
  • 7.3.5. Spain Cellular Health Screening Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Sample
      • 7.3.5.2.3. By Site of Collection

8. Asia-Pacific Cellular Health Screening Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Sample
  • 8.2.3. By Site of Collection
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Cellular Health Screening Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Sample
      • 8.3.1.2.3. By Site of Collection
  • 8.3.2. India Cellular Health Screening Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Sample
      • 8.3.2.2.3. By Site of Collection
  • 8.3.3. Japan Cellular Health Screening Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Sample
      • 8.3.3.2.3. By Site of Collection
  • 8.3.4. South Korea Cellular Health Screening Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Sample
      • 8.3.4.2.3. By Site of Collection
  • 8.3.5. Australia Cellular Health Screening Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Sample
      • 8.3.5.2.3. By Site of Collection

9. South America Cellular Health Screening Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Sample
  • 9.2.3. By Site of Collection
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Cellular Health Screening Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Sample
      • 9.3.1.2.3. By Site of Collection
  • 9.3.2. Argentina Cellular Health Screening Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Sample
      • 9.3.2.2.3. By Site of Collection
  • 9.3.3. Colombia Cellular Health Screening Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Sample
      • 9.3.3.2.3. By Site of Collection

10. Middle East and Africa Cellular Health Screening Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Sample
  • 10.2.3. By Site of Collection
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Cellular Health Screening Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Sample
      • 10.3.1.2.3. By Site of Collection
  • 10.3.2. Saudi Arabia Cellular Health Screening Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Sample
      • 10.3.2.2.3. By Site of Collection
  • 10.3.3. UAE Cellular Health Screening Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Sample
      • 10.3.3.2.3. By Site of Collection

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Product Offerings
• 13.3. Recent Developments
• 13.4. Financials (As Reported)
• 13.5. Key Personnel
• 13.6. SWOT Analysis
  • 13.6.1. Telomere Diagnostics, Inc.
  • 13.6.2. Quest Diagnostics, Inc.
  • 13.6.3. Laboratory Corporation of America Holdings
  • 13.6.4. SpectraCell Laboratories, Inc.
  • 13.6.5. Cell Science Systems Corporation
  • 13.6.6. Immundiagnostik AG
  • 13.6.7. Repeat Diagnostics, Inc.
  • 13.6.8. OPKO Health, Inc.
  • 13.6.9. Genova Diagnostics, Inc.
  • 13.6.10. Titanovo, Inc.

14. Strategic Recommendations